Does Phosphodiesterase 11A (PDE11A) Hold Promise as a Future Therapeutic Target?

E-ISSN： 1873-4286|21|3|389-416

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.3, 2015-01, pp. : 389-416

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic approaches in treating Creutzfeldt-Jakob disease – what does the future hold?

By Croes Esther A

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2391-2396

Informa Healthcare

Access to resources Recommend Favorite

11β-Hydroxysteroid dehydrogenase-1 as a therapeutic target for metabolic diseases

By Fotsch Christopher Askew Ben C Chen Jian Jeffrey

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 3, 2005-03 ,pp. : 289-303

Informa Healthcare

Access to resources Recommend Favorite

New Therapeutic Applications of Phosphodiesterase 5 Inhibitors (PDE5-Is)

Current Medicinal Chemistry, Vol. 23, Iss. 12, 2016-05 ,pp. : 1239-1249

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?

By Teixeira M.M. Gristwood R.W. Cooper N. Hellewell P.G.

Trends in Pharmacological Sciences, Vol. 18, Iss. 5, 1997-05 ,pp. : 164-170

Elsevier

Access to resources Recommend Favorite

Phosphodiesterase Inhibition as a Therapeutic Target for Brain Ischemia

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 8, 2015-10 ,pp. : 1012-1023

Bentham Science Publishers

Access to resources Recommend Favorite